Phosphodiesterase 4 Inhibitor [EPC]

163127 reported adverse events

Drugs of this class: ROFLUMILAST APREMILAST CRISABOROLE DIFAMILAST ENSIFENTRINE

These side effects are most commonly reported by patients taking drugs of the Phosphodiesterase 4 Inhibitor [EPC] class:

# Side effect Count
0 DIARRHOEA 25491
1 NAUSEA 22866
2 PSORIASIS 20775
3 HEADACHE 18572
4 DRUG INEFFECTIVE 18232
5 ABDOMINAL DISCOMFORT 8477
6 PSORIATIC ARTHROPATHY 8345
7 PAIN 7772
8 RASH 7683
9 VOMITING 6833
See all common reactions for Phosphodiesterase 4 Inhibitor [EPC]

Drugs of the Phosphodiesterase 4 Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 437 0.6542
1 C-REACTIVE PROTEIN 509 0.5491
2 LUPUS VULGARIS 643 0.5103
3 DEEP VEIN THROMBOSIS POSTOPERATIVE 1005 0.5017
4 RHEUMATIC FEVER 2214 0.4962
5 SWOLLEN JOINT COUNT INCREASED 1574 0.4931
6 FACET JOINT SYNDROME 1446 0.4437
7 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 811 0.3910
8 RETINITIS 643 0.3719
9 DISLOCATION OF VERTEBRA 819 0.3587
See all enriched reactions for Phosphodiesterase 4 Inhibitor [EPC]